{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T10:57:59Z","timestamp":1784285879270,"version":"3.55.0"},"reference-count":0,"publisher":"Dustri-Verlag Dr. Karl Feistle","issue":"03","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CP"],"published-print":{"date-parts":[[2025,3,1]]},"DOI":"10.5414\/cp204645","type":"journal-article","created":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T14:04:28Z","timestamp":1737554668000},"page":"98-104","source":"Crossref","is-referenced-by-count":2,"title":["Sodium-glucose cotransporter-2 inhibitor treatment has differential effects on the incidence of various malignancies: Evidence from a spontaneous adverse reaction database"],"prefix":"10.5414","volume":"63","author":[{"given":"Ryo","family":"Inose","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichi","family":"Muraki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3374","container-title":["Int. Journal of Clinical Pharmacology and Therapeutics"],"original-title":[],"language":"en","deposited":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T15:41:12Z","timestamp":1739547672000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dustri.com\/article_response_page.html?artId=191805&doi=10.5414\/CP204645&L=0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,1]]},"references-count":0,"journal-issue":{"issue":"03","published-print":{"date-parts":[[2025]]}},"alternative-id":["204645"],"URL":"https:\/\/doi.org\/10.5414\/cp204645","relation":{},"ISSN":["0946-1965"],"issn-type":[{"value":"0946-1965","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3,1]]}}}